| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 8.971 | 9.687 | 1.679 | 0 | 0 | 0 | 11.660 | 46.579 | 87.905 |
| Total Income - EUR | - | 8.971 | 9.687 | 1.679 | 0 | 0 | 0 | 11.660 | 46.579 | 87.905 |
| Total Expenses - EUR | - | 3.097 | 3.972 | 2.457 | 267 | 74 | 73 | 1.495 | 5.188 | 3.961 |
| Gross Profit/Loss - EUR | - | 5.874 | 5.715 | -778 | -267 | -74 | -73 | 10.165 | 41.391 | 83.943 |
| Net Profit/Loss - EUR | - | 5.605 | 5.424 | -828 | -267 | -74 | -73 | 9.815 | 35.563 | 70.781 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mvf Sedaclin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 19 | 537 | 194 | 0 | 0 | 0 | 712 | 11.952 | 13.350 |
| Current Assets | - | 5.778 | 10.441 | 9.755 | 4.431 | 4.273 | 4.105 | 9.331 | 29.439 | 138.458 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 846 | 1.007 | 3.782 | 3.435 | 3.783 | 3.699 | 7.600 | 26.301 | 131.761 |
| Cash | - | 4.931 | 9.434 | 5.973 | 997 | 490 | 406 | 1.732 | 3.138 | 6.697 |
| Shareholders Funds | - | 5.650 | 10.979 | 9.949 | 4.431 | 4.273 | 4.105 | 9.864 | 39.962 | 75.155 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 147 | 0 | 0 | 0 | 0 | 0 | 179 | 1.428 | 76.653 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mvf Sedaclin Srl